Literature DB >> 33535566

The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Waleed N Qaddumi1, Pedro A Jose2.   

Abstract

The kidney is critical in the long-term regulation of blood pressure. Oxidative stress is one of the many factors that is accountable for the development of hypertension. The five dopamine receptor subtypes (D1R-D5R) have important roles in the regulation of blood pressure through several mechanisms, such as inhibition of oxidative stress. Dopamine receptors, including those expressed in the kidney, reduce oxidative stress by inhibiting the expression or action of receptors that increase oxidative stress. In addition, dopamine receptors stimulate the expression or action of receptors that decrease oxidative stress. This article examines the importance and relationship between the renal dopaminergic system and oxidative stress in the regulation of renal sodium handling and blood pressure. It discusses the current information on renal dopamine receptor-mediated antioxidative network, which includes the production of reactive oxygen species and abnormalities of renal dopamine receptors. Recognizing the mechanisms by which renal dopamine receptors regulate oxidative stress and their degree of influence on the pathogenesis of hypertension would further advance the understanding of the pathophysiology of hypertension.

Entities:  

Keywords:  blood pressure; dopamine; dopamine receptor; dopaminergic system; hypertension; kidney; oxidative stress

Year:  2021        PMID: 33535566      PMCID: PMC7912729          DOI: 10.3390/biomedicines9020139

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  264 in total

1.  The influence of Vicia faba (broad bean) seedlings on urinary sodium excretion.

Authors:  Y Vered; I Grosskopf; D Palevitch; A Harsat; G Charach; M S Weintraub; E Graff
Journal:  Planta Med       Date:  1997-06       Impact factor: 3.352

2.  Potassium intake modulates the thiazide-sensitive sodium-chloride cotransporter (NCC) activity via the Kir4.1 potassium channel.

Authors:  Ming-Xiao Wang; Catherina A Cuevas; Xiao-Tong Su; Peng Wu; Zhong-Xiuzi Gao; Dao-Hong Lin; James A McCormick; Chao-Ling Yang; Wen-Hui Wang; David H Ellison
Journal:  Kidney Int       Date:  2018-01-06       Impact factor: 10.612

3.  Expression of the dopamine D3 receptor protein in the rat kidney.

Authors:  D P O'Connell; C J Vaughan; A M Aherne; S J Botkin; Z Q Wang; R A Felder; R M Carey
Journal:  Hypertension       Date:  1998-11       Impact factor: 10.190

4.  Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion.

Authors:  S G Ball; N S Oats; M R Lee
Journal:  Clin Sci Mol Med       Date:  1978-08

Review 5.  The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction.

Authors:  Mark C Houston
Journal:  Altern Ther Health Med       Date:  2007 Mar-Apr       Impact factor: 1.305

6.  Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension.

Authors:  Leticia Gonzalez; Ulises Novoa; Jackeline Moya; Luigi Gabrielli; Jorge E Jalil; Lorena García; Mario Chiong; Sergio Lavandero; María Paz Ocaranza
Journal:  Biochem Pharmacol       Date:  2018-09-01       Impact factor: 5.858

Review 7.  Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension.

Authors:  Allen W Cowley; Michiaki Abe; Takefumi Mori; Paul M O'Connor; Yusuke Ohsaki; Nadezhda N Zheleznova
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-29

8.  IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Authors:  Emmanuella Guenova; Yuliya Skabytska; Wolfram Hoetzenecker; Günther Weindl; Karin Sauer; Manuela Tham; Kyu-Won Kim; Ji-Hyeon Park; Ji Hae Seo; Desislava Ignatova; Antonio Cozzio; Mitchell P Levesque; Thomas Volz; Martin Köberle; Susanne Kaesler; Peter Thomas; Reinhard Mailhammer; Kamran Ghoreschi; Knut Schäkel; Boyko Amarov; Martin Eichner; Martin Schaller; Rachael A Clark; Martin Röcken; Tilo Biedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  The dopamine prodrug, gludopa, decreases both renal and extrarenal noradrenaline spillover in conscious rabbits.

Authors:  Z Q Wang; K Shimizu; D Way; J Secombe; B P McGrath
Journal:  Clin Exp Pharmacol Physiol       Date:  1993-05       Impact factor: 2.557

10.  Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.

Authors:  Xiaoliang Jiang; Prasad Konkalmatt; Yu Yang; John Gildea; John E Jones; Santiago Cuevas; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

View more
  5 in total

Review 1.  Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease.

Authors:  Robin A Felder; John J Gildea; Peng Xu; Wei Yue; Ines Armando; Robert M Carey; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2022-06-16       Impact factor: 4.592

Review 2.  Sorting nexins: role in the regulation of blood pressure.

Authors:  Juan Huang; Andrew C Tiu; Pedro A Jose; Jian Yang
Journal:  FEBS J       Date:  2021-11-30       Impact factor: 5.622

3.  Alamandine alleviates hypertension and renal damage via oxidative-stress attenuation in Dahl rats.

Authors:  Juexiao Gong; Man Luo; Yonghong Yong; Shan Zhong; Peng Li
Journal:  Cell Death Discov       Date:  2022-01-12

4.  Synergistic Effect of Uroguanylin and D1 Dopamine Receptors on Sodium Excretion in Hypertension.

Authors:  Cindy Zeng; Tianyang Xia; Shuo Zheng; Lijia Liang; Yue Chen
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

Review 5.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.